Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?

Sünnetçioğlu A., Sünnetçioğlu M., Adiyaman F., Binici I., Soyoral L.

CLINICAL RESPIRATORY JOURNAL, vol.11, no.6, pp.925-930, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 6
  • Publication Date: 2017
  • Doi Number: 10.1111/crj.12438
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.925-930
  • Keywords: C reactive protein, leukocyte count, ventilator-associated pneumonia, soluble urine plasminogen kinase activator, C-REACTIVE PROTEIN, ACTIVATOR RECEPTOR, PROGNOSTIC BIOMARKER, CELL COUNT, MORTALITY, CHILDREN, SEPSIS
  • Van Yüzüncü Yıl University Affiliated: Yes


BackgroundSoluble urokinase plasminogen activator receptor (suPAR) is a biomarker that is increasingly used for evaluation of systemic inflammation. This study was performed to investigate whether suPAR may possess a diagnostic value in patients with ventilator-associated pneumonia (VAP).